Ignite Creation Date:
2025-12-24 @ 6:57 PM
Ignite Modification Date:
2026-04-15 @ 3:28 AM
Study NCT ID:
NCT00860457
Status:
COMPLETED
Last Update Posted:
2018-11-21
First Post:
2009-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Georgetown University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2009-03-10
First Submit QC Date:
None
Study First Post Date:
2009-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-02-24
Results First Submit QC Date:
None
Results First Post Date:
2014-08-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-23
Last Update Post Date:
2018-11-21
Last Update Post Date Type:
ACTUAL